Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01631461
Other study ID # PainBreastfeed
Secondary ID
Status Completed
Phase N/A
First received June 12, 2012
Last updated November 14, 2016
Start date December 2006
Est. completion date December 2009

Study information

Verified date November 2016
Source Göteborg University
Contact n/a
Is FDA regulated No
Health authority Sweden: Swedish National Council on Medical Ethics
Study type Observational

Clinical Trial Summary

The aim of this study is to investigate the prevalence of yeast and bacteria in women with breastfeeding pain and to identify signs and symptoms.


Description:

Painful breastfeeding is one of the most common reasons for early weaning. Persistent pain associated with breastfeeding can sometimes be difficult to diagnose and is a source of frustration for the breastfeeding women as well as for healthcare providers.

The diagnosis of candida infection in breastfeeding women is generally based on signs and symptoms identified in case reports and without any culture. Breastfeeding pain has been described as superficial or deep in some studies. This deep pain syndrome as caused by candida or bacteria has been questioned. A few studies have cultured breast milk from women with deep breast pain and found Candida albicans infections or bacterial infections usually caused by Staphylococcus aureus. There still remains controversy and lack of evidence for candidiasis affecting the lactating breast as well as bacteria causing the pain. Ensured diagnostic methods are important due to the resistant problem with both antibiotics and antifungals. Only one study has described five key symptoms associated with candida. It was shiny, flaky nipple/areola, burning pain on the nipple/areola, non-stabbing pain or stabbing pain in the breast.

The objective of this study was to investigate the prevalence of candida and bacteria in women with superficial or deep breastfeeding pain and to identify signs and symptoms linked to candida or bacteria in breast milk and nipple/areola.


Recruitment information / eligibility

Status Completed
Enrollment 136
Est. completion date December 2009
Est. primary completion date December 2009
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria:

- scored pain > = VAS 4

Exclusion Criteria:

- breastfeeding technique problems

- clinical signs of mastitis

- muscular pain

- breast surgery

- use of antibiotic or antifungal treatment during the last preceding week

- temperature > = 37 degree Celsius

Study Design

Observational Model: Case Control, Time Perspective: Prospective


Related Conditions & MeSH terms


Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
Göteborg University Vastra Gotaland Region

Outcome

Type Measure Description Time frame Safety issue
Primary Bacteria Occurrence of bacteria: yes/no Baseline (at admission) Yes
Primary Yeast Occurence of yeast: yes/no Baseline (at admission) Yes
Secondary Pain VAS Baseline (at admission) Yes
Secondary Signs Nipple areola: cracks, red/pink, flaky, shiny, blurred, swollen, itching, smarting Baseline (at admission) Yes
Secondary Bacteria at follow-up Occurence of bacteria: yes/no 2 weeks after baseline Yes
Secondary Yeast at follow-up Occurence of yeast: yes/no 2 weeks after baseline Yes
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05762016 - Outcomes of a Novel Technique of Mini- Incision and Self-Express (MISE) for Breast Abscess